Alliance Pharmaceutical Corp. Completes The Manufacture Of Oxygent (TM) For Clinical Trials
Wed, 07 Feb 2007 08:00 AM EST
... Alliance Pharmaceutical Corp. (OTC Bulletin Board: ALLP) today announces the manufacture and release for shipment of Oxygent (TM) (perfluorochemical [PFC] emulsion) for clinical trials.The clinical supplies will be used in the Phase 2 Proof of Concept trial that will be conducted in Europe and by Alliance's partner in China, Beijing Double-Crane Pharmaceutical Co. Ltd. [click link for full article] ...
Related Topics
- Clinical Trials
- Pharmacology
- Psychopharmacology
- Clinical Growth Charts
- Pediatric Aids
- Drug Information
- Hypnotherapy
- Epidemiology
- Clinical Laboratory Improvement Amendments
- Depression
- Infectious Diseases
- Western/Clinical Treatment and Therapy
- Pediatric Care
- Ovarian Cancer
- Epidemiology & Prevention of Vaccine-Preventable Diseases
- Tacrine
- Guanfacine
- Didanosine
- Albendazole
- Drug and Medical Device Safety

Not Signed In -

